Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic Cardiomyopathy,

Mavacamten is the first ever drug to be approved for HOCM found to improve symptoms and may … Dr. Emani was not involved in the clinical trials., Mavacamten is the first ever drug to be approved for HOCM found to improve symptoms and may … Dr. Emani was not involved in the clinical trials., Read More

Scroll to Top